Form 4 for KRSA Korsana Biosciences, Inc.
Accepted 2023-08-11 00:00:00 ET · period of report 2023-08-09 · accession 0000899243-23-018047 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2023-08-11 | 2023-08-09 | KRSA | MCGUIRE TERRANCE | Dir | S - Sale | $3.40 | -8 | 0 | -100% | -$27.20 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-09 | S | D | 8 | $3.40 | 0 | I By Polaris Venture Management Co. II, L.L.C. | — | — | (F1) On May 15, 2023, the Issuer effected a 1-for-20 reverse stock split of all of its shares of Common Stock resulting in a corresponding reduction of the Reporting Person's direct and indirect ownership of Common Stock. (F2) The Reporting Person and Jonathan Flint ("Flint") are the managing members of Polaris Venture Management Co. II, L.L.C., the beneficial owner of the securities. Each of the Reporting Person and Flint disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. |